Just like Papa elephants love their calves. Everyone deserves to know what they put in their kids’ bodies, honestly.

Follow Us

Getilapson Chromium Picolinate

$195.99

  • Purpose: Dietary Supplement
  • Active Ingredients: Chromium Picolinate 200mcg
  • Directions: Take one (1) Capsule daily, preferably with a meal, As a reminder, discuss the supplements and medications you take with your health care providers. Store in a dry place and avoid excessive heat.
SKU: GT0310 Category: Tag:

Description

Research & Study

Clinical studies on chromium picolinate supplementation in diabetes mellitus–a review.

Abstract
Chromium (Cr) picolinate (CrPic) is a widely used nutritional supplement for optimal insulin function. A relationship among Cr status, diabetes, and associated pathologies has been established. Virtually all trials using CrPic supplementation for subjects with diabetes have demonstrated beneficial effects. Thirteen of 15 clinical studies (including 11 randomized, controlled studies) involving a total of 1,690 subjects (1,505 in CrPic group) reported significant improvement in at least one outcome of glycemic control. All 15 studies showed salutary effects in at least one parameter of diabetes management, including dyslipidemia. Positive outcomes from CrPic supplementation included reduced blood glucose, insulin, cholesterol, and triglyceride levels and reduced requirements for hypoglycemic medication. The greater bioavailability of CrPic compared with other forms of Cr (e.g., niacin-bound Cr or CrCl(3)) may explain its comparatively superior efficacy in glycemic and lipidemic control. The pooled data from studies using CrPic supplementation for type 2 diabetes mellitus subjects show substantial reductions in hyperglycemia and hyperinsulinemia, which equate to a reduced risk for disease complications. Collectively, the data support the safety and therapeutic value of CrPic for the management of cholesterolemia and hyperglycemia in subjects with diabetes.
PMID:17109600
 
[PubMedindexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/17109600    

Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.

Abstract
Intervention trials have shown the beneficial effects of chromium supplementation in type 2 diabetes (non-insulin-dependent diabetes mellitus). This study investigated the effects of chromium picolinate on elderly diabetic patients within a rehabilitation program. Thirty-nine diabetic subjects, average age 73 years (18 males and 21 females), undergoing rehabilitation following stroke or hip fracture, were recruited to participate in this study. An additional 39 diabetic patients constituted the control group. Along with standard treatment for diabetes, the study group received 200 microg of chromium twice a day for a three-week period. Blood samples, dietary intake, and anthropometric data were collected prior to and post-intervention. Throughout the study period, participants received a diet of approximately 1500 kcal/day. Significant differences in the fasting blood level of glucose compared to the baseline (190 mg/dL vs 150 mg/dL, p < 0.001) were found at the end of the study. HbA1c also improved from 8.2% to 7.6% (p < 0.01). Total cholesterol was also reduced from 235 mg/dL to 213 mg/dL (p < 0.02). A trend towards lowered triglyceride levels was also observed (152 mg/dL vs 136 mg/dL). We conclude that, in this population of elderly, diabetic patients undergoing rehabilitation, dietary supplementation with chromium is beneficial in moderating glucose intolerance. In addition, chromium intake appears to lower plasma lipid levels.
PMID: 15296075
 
[PubMed – indexed for MEDLINE]   http://www.ncbi.nlm.nih.gov/pubmed/15296075

Additional information

Weight 100 oz
CHOOSE DELIVERY

Monthly Subscription, Save 10%, One-time purchase

CHOOSE QUANTITY

30-Day Supply Bottle

Reviews

There are no reviews yet.

Be the first to review “Getilapson Chromium Picolinate”

Your email address will not be published. Required fields are marked *